Gary D Hutchins Selected Research

Carbon-11

11/2009	Synthesis of carbon-11 labeled celecoxib derivatives as new candidate PET radioligands for imaging of inflammation.
4/2008	Synthesis of new carbon-11 labeled cyclofenil derivatives for PET imaging of breast cancer estrogen receptors.
12/2006	Synthesis of carbon-11 labeled fluorinated 2-arylbenzothiazoles as novel potential PET cancer imaging agents.
11/2006	Synthesis of radiolabeled stilbene derivatives as new potential PET probes for aryl hydrocarbon receptor in cancers.
1/2005	Synthesis of 2-amino-6-(4-[11C]methoxyphenylthio)-9-[2-(phosphonomethoxy)ethyl]purine bis(2,2,2-trifluoroethyl) ester as a novel potential PET gene reporter probe for HBV and HSV-tk in cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gary D Hutchins Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 11/2002
15	Breast Neoplasms (Breast Cancer) 12/2010 - 10/2002
9	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 06/2004
6	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 04/2010
4	Neuroinflammatory Diseases 01/2017 - 06/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 07/2013
2	Obesity 07/2013 - 01/2010
2	Inflammation (Inflammations) 01/2013 - 11/2009
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Erectile Dysfunction 01/2023
1	Glioma (Gliomas) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Ischemia 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Hemorrhage 10/2017
1	Shock 10/2017
1	Neoplasm Metastasis (Metastasis) 03/2017
1	Brain Diseases (Brain Disorder) 01/2017
1	Cognitive Dysfunction 01/2017
1	Atrophy 01/2017
1	Pain (Aches) 01/2016
1	Fibromyalgia (Fibrositis) 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 10/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2014
1	Acute Lung Injury 09/2014
1	Hypoxia (Hypoxemia) 09/2014
1	Frontotemporal Dementia (Semantic Dementia) 01/2014
1	Tauopathies 01/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2013
1	Neutropenia 12/2012
1	Plexiform Neurofibroma 12/2012
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2012
1	Bipolar Disorder (Manic Depressive Psychosis) 06/2011
1	Chronic Limb-Threatening Ischemia 06/2011

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2004
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2003
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2006
5	Carbon-11IBA 11/2009 - 01/2005
4	AntigensIBA 01/2020 - 12/2005
3	gallium 68 PSMA-11IBA 02/2024 - 11/2023
3	Antineoplastic Agents (Antineoplastics)IBA 03/2010 - 11/2004
3	EnzymesIBA 11/2009 - 11/2004
3	EstersIBA 01/2006 - 07/2003
3	Matrix Metalloproteinase InhibitorsIBA 10/2003 - 10/2002
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018 - 07/2013
2	Insulin (Novolin)FDA Link 01/2018 - 07/2013
2	Acetates (Acetic Acid Esters)FDA Link 03/2017 - 04/2008
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 10/2015
2	Dopamine (Intropin)FDA LinkGeneric 01/2016 - 06/2011
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 06/2011 - 12/2004
2	Aromatase (CYP19)IBA 12/2010 - 11/2009
2	Estrogen ReceptorsIBA 11/2009 - 04/2008
2	Fluorouracil (Carac)FDA LinkGeneric 09/2007 - 11/2004
2	Fluorine-18IBA 11/2006 - 11/2004
2	Hormones (Hormone)IBA 10/2006 - 12/2005
2	purineIBA 01/2005 - 05/2003
2	Choline (Choline Chloride)IBA 06/2004 - 11/2002
2	Matrix Metalloproteinases (MMPs)IBA 07/2003 - 10/2002
2	O(6)-benzylguanineIBA 05/2003 - 02/2003
1	Investigational DrugsIBA 01/2023
1	Amino Acids FDA Link 01/2022
1	RG7388IBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	von Willebrand FactorIBA 01/2022
1	RadiopharmaceuticalsIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	Liraglutide FDA Link 01/2018
1	PSMA-11IBA 03/2017
1	Purinergic P2X7 ReceptorsIBA 01/2017
1	Purinergic P2X4 ReceptorsIBA 01/2017
1	Purinergic Receptors (Receptors, Purine)IBA 01/2017
1	fallyprideIBA 01/2016
1	LipopolysaccharidesIBA 03/2015
1	EndotoxinsIBA 03/2015
1	CopperIBA 01/2015
1	Yttrium-90IBA 10/2014
1	HMGB1 Protein (HMG1)IBA 09/2014
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2014
1	Transaminases (Aminotransferases)IBA 12/2012
1	Imatinib Mesylate (Gleevec)FDA Link 12/2012
1	Cholinesterases (Cholinesterase)IBA 04/2011
1	Carbolines (Beta-Carbolines)IBA 04/2011
1	NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA 12/2010
1	6- methoxy- 9- methyl- (1,3)dioxolo(4,5- h)quinolin- 8(9H)- oneIBA 12/2010
1	LipidsIBA 10/2010
1	CholesterolIBA 10/2010

Therapy/Procedure

6	Therapeutics 01/2022 - 11/2004
4	Drug Therapy (Chemotherapy) 08/2010 - 01/2005
3	Prostatectomy (Retropubic Prostatectomy) 01/2024 - 01/2023
3	Intravenous Administration 01/2020 - 01/2015
2	Aftercare (After-Treatment) 01/2022 - 09/2007
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 10/2017
1	Microspheres (Microsphere) 10/2014
1	Lung Transplantation 09/2014
1	Transplantation 09/2014
1	Chemoradiotherapy 12/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2011
1	Surgical Amputation (Amputations) 06/2011